The Latest Cardiac and Vascular News
MOUNTAIN VIEW, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) — Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today announced the appointment of Mr. Ed Roschak as its president and chief executive officer. “We are fortunate that […]
ATLANTA, Dec. 1, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of JOTEC AG, a German-based, privately-held developer of technologically differentiated endovascular stent grafts, and cardiac and vascular surgical […]
TEL AVIV, ISRAEL — (Marketwired) — Nov 29, 2017 — InspireMD Ltd. (NYSE MKT: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that it entered into a securities purchase agreement with an institutional investor for the issuance and sale of 750 shares of InspireMD’s […]
MENLO PARK, Calif.–(BUSINESS WIRE)–Qool Therapeutics, Inc., a company developing a novel non-invasive targeted temperature management system, has raised an $8 million Series A-1 round for clinical product development and to prepare for first-in-human studies. The funding was provided by Zhongji Holdings LTD/Join Medical Technology, TAMCAP LLC, BrilliMedical International Corp., BioPacific […]
EDEN PRAIRIE, Minn., Nov. 27, 2017 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS) announced today the closing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts and commissions and offering expenses payable by CHF […]
Maquet files new patent infringement dispute based on a patent from earlier this year Maquet opens a new front in patent war with Abiomed NOVEMBER 28, 2017 BY BRAD PERRIELLO, MassDevice Getinge (PINK:GETI B) subsidiary Maquet opened a new front last week in its patent war with Abiomed (NSDQ:ABMD), alleging infringement of a patent granted earlier this […]
QUEBEC CITY, Nov. 27, 2017 /CNW Telbec/ – Opsens Inc. (“Opsens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical Inc. (“Zeon Medical”), Opsens’ Japanese partner. Zeon Medical has been a client of Opsens since 2004. In 2012, Opsens granted Zeon Medical the exclusive distribution […]
MARLBOROUGH, Mass., Nov. 27, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in the Citi 2017 Global Healthcare Conference on December 7, 2017 in New York. Kevin Ballinger, executive vice president and president, interventional cardiology, and Susie Lisa, vice president, investor relations, will participate in a 40-minute question-and-answer session with the host analyst beginning at approximately 8:45 […]
EDEN PRAIRIE, Minn., Nov. 22, 2017 (GLOBE NEWSWIRE) — CHF Solutions(NASDAQ:CHFS) announced today the pricing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts and commissions and offering expenses payable by CHF Solutions. The Series F […]
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]
